中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 5
May  2022
Turn off MathJax
Article Contents

Advances in the clinical research on liver transplantation in treatment of acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2022.05.045
Research funding:

Nation Natural Science Foundation of China (General Program) (82072219);

Natural Science Foundation of Tianjin (17JCQNJC12800)

More Information
  • Corresponding author: LI Jiang, lijiang_009@163.com(ORCID: 0000-0002-2368-9942)
  • Received Date: 2021-09-14
  • Accepted Date: 2021-10-18
  • Published Date: 2022-05-20
  • Acute-on-chronic liver failure (ACLF) is a disease of rapid deterioration of liver function caused by the acute exacerbation of chronic liver diseases, and it is often associated with multiple organ failure and has a poorer prognosis than common liver cirrhosis. Many studies suggest that timely liver transplantation can significantly improve the survival rate of patients with ACLF; however, there are currently no reliable guidelines that point out the indications for liver transplantation in patients with ACLF. This article summarizes recent studies and discusses the indication, timing, and prognosis of liver transplantation in ALCF patients.

     

  • loading
  • [1]
    FERNÁNDEZ J, SALIBA F. Liver transplantation in patients with ACLF and multiple organ failure: Time for priority after initial stabilization[J]. J Hepatol, 2018, 69(5): 1004-1006. DOI: 10.1016/j.jhep.2018.09.002.
    [2]
    WU T, SUNDARAM V. Transplantation for acute-on-chronic liver failure[J]. Clin Liver Dis (Hoboken), 2019, 14(4): 152-155. DOI: 10.1002/cld.852.
    [3]
    ARTRU F, LOUVET A, RUIZ I, et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3[J]. J Hepatol, 2017, 67(4): 708-715. DOI: 10.1016/j.jhep.2017.06.009.
    [4]
    CHOUDHURY A, KUMAR M, SHARMA BC, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study[J]. J Gastroenterol Hepatol, 2017, 32(12): 1989-1997. DOI: 10.1111/jgh.13799.
    [5]
    BAJAJ JS, MOREAU R, KAMATH PS, et al. Acute-on-chronic liver failure: Getting ready for prime time?[J]. Hepatology, 2018, 68(4): 1621-1632. DOI: 10.1002/hep.30056.
    [6]
    JALAN R, PAVESI M, SALIBA F, et al. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure[J]. J Hepatol, 2015, 62(4): 831-840. DOI: 10.1016/j.jhep.2014.11.012.
    [7]
    WLODZIMIROW KA, ESLAMI S, ABU-HANNA A, et al. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality[J]. Liver Int, 2013, 33(1): 40-52. DOI: 10.1111/j.1478-3231.2012.02790.x.
    [8]
    SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update[J]. Hepatol Int, 2019, 13(4): 353-390. DOI: 10.1007/s12072-019-09946-3.
    [9]
    MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144(7): 1426-1437. e1-e9. DOI: 10.1053/j.gastro.2013.02.042.
    [10]
    DUSEJA A, SINGH SP. Toward a better definition of acute-on-chronic liver failure[J]. J Clin Exp Hepatol, 2017, 7(3): 262-265. DOI: 10.1016/j.jceh.2017.05.002.
    [11]
    GUSTOT T, JALAN R. Acute-on-chronic liver failure in patients with alcohol-related liver disease[J]. J Hepatol, 2019, 70(2): 319-327. DOI: 10.1016/j.jhep.2018.12.008.
    [12]
    SHANG DB, XIANG XG. Advances in the pathogenesis and treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(4): 765-769. DOI: 10.3969/j.issn.1001-5256.2021.04.005.

    尚大宝, 项晓刚. 慢加急性肝衰竭的发病机制和治疗进展[J]. 临床肝胆病杂志, 2021, 37(4): 765-769. DOI: 10.3969/j.issn.1001-5256.2021.04.005.
    [13]
    SHALIMAR, KUMAR D, VADIRAJA PK, et al. Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality[J]. J Gastroenterol Hepatol, 2016, 31(4): 856-864. DOI: 10.1111/jgh.13213.
    [14]
    PAMECHA V, KUMAR S, BHARATHY KG. Liver transplantation in acute on chronic liver failure: Challenges and an algorithm for patient selection and management[J]. Hepatol Int, 2015, 9(4): 534-542. DOI: 10.1007/s12072-015-9646-9.
    [15]
    KABBANI AR, TERGAST TL, MANNS MP, et al. Treatment strategies for acute-on-chronic liver failure[J]. Med Klin Intensivmed Notfmed, 2021, 116(1): 3-16. DOI: 10.1007/s00063-019-00613-x.
    [16]
    WONG F, PIANO S, SINGH V, et al. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure[J]. J Hepatol, 2021, 74(2): 330-339. DOI: 10.1016/j.jhep.2020.07.046.
    [17]
    LIN KH, LIU JW, CHEN CL, et al. Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation[J]. PLoS One, 2013, 8(9): e72893. DOI: 10.1371/journal.pone.0072893.
    [18]
    ARTRU F, LOUVET A, RUIZ I, et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3[J]. J Hepatol, 2017, 67(4): 708-715. DOI: 10.1016/j.jhep.2017.06.009.
    [19]
    CHOUDHURY A, JINDAL A, MAIWALL R, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): Comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models[J]. Hepatol Int, 2017, 11(5): 461-471. DOI: 10.1007/s12072-017-9816-z.
    [20]
    ZHANG L, ZHANG WQ, XIE Y, et al. Clinical observation of liver transplantation in the treatment of 17 cases of acute-on-chronic liver failure induced by discontinuation of nucleoside analogues[J/CD]. Prac J Organ Transplant(Electronic Version), 2021, 9(1): 46-49. DOI: 10.3969/j.issn.2095-5332.2021.01.011.

    张骊, 张炜琪, 谢炎, 等. 肝移植治疗因停用核苷类似物导致的慢加急性肝衰竭17例临床观察[J/CD]. 实用器官移植电子杂志, 2021, 9(1): 46-49. DOI: 10.3969/j.issn.2095-5332.2021.01.011.
    [21]
    MOON DB, LEE SG, KANG WH, et al. Adult living donor liver transplantation for acute-on-chronic liver failure in high-model for end-stage liver disease score patients[J]. Am J Transplant, 2017, 17(7): 1833-1842. DOI: 10.1111/ajt.14198.
    [22]
    KNAAK J, MCVEY M, BAZERBACHI F, et al. Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubation[J]. Liver Transpl, 2015, 21(6): 761-767. DOI: 10.1002/lt.24115.
    [23]
    PETROWSKY H, RANA A, KALDAS FM, et al. Liver transplantation in highest acuity recipients: Identifying factors to avoid futility[J]. Ann Surg, 2014, 259(6): 1186-1194. DOI: 10.1097/SLA.0000000000000265.
    [24]
    UMGELTER A, LANGE K, KORNBERG A, et al. Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: A single-center experience[J]. Transplant Proc, 2011, 43(10): 3762-3768. DOI: 10.1016/j.transproceed.2011.08.110.
    [25]
    DUAN BW, LU SC, WANG ML, et al. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: A single center experience of 100 consecutive cases[J]. J Surg Res, 2013, 183(2): 936-943. DOI: 10.1016/j.jss.2013.03.008.
    [26]
    CHOK KSH, CHAN SC, FUNG JY, et al. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(3): 256-262. DOI: 10.1016/s1499-3872(13)60042-9.
    [27]
    GUSTOT T, FERNANDEZ J, GARCIA E, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis[J]. Hepatology, 2015, 62(1): 243-252. DOI: 10.1002/hep.27849.
    [28]
    PUTIGNANO A, GUSTOT T. New concepts in acute-on-chronic liver failure: Implications for liver transplantation[J]. Liver Transpl, 2017, 23(2): 234-243. DOI: 10.1002/lt.24654.
    [29]
    LI S, LIU J, CHEN Y. Non-bioartificial liver in liver failure: Clinical application and research advances[J]. J Clin Hepatol, 2019, 35(9): 1909-1915. DOI: 10.3969/j.issn.1001-5256.2019.09.004.

    李爽, 刘静, 陈煜. 非生物型人工肝在肝衰竭中的临床应用及进展[J]. 临床肝胆病杂志, 2019, 35(9): 1909-1915. DOI: 10.3969/j.issn.1001-5256.2019.09.004.
    [30]
    TANDON R, FROGHI S. Artificial liver support systems[J]. J Gastroenterol Hepatol, 2021, 36(5): 1164-1179. DOI: 10.1111/jgh.15255.
    [31]
    XU KL, LEI M, YUAN WF, et al. Effect of dual plasma molecular adsorption system in the treatment of hyperbilirubinemia in patients with liver failure[J]. Traum Crit Med, 2020, 8(2): 91-93, 96. DOI: 10.16048/j.issn.2095-5561.2020.02.08.

    许开亮, 雷鸣, 袁维方, 等. 双重血浆分子吸附系统治疗肝衰竭高胆红素患者疗效研究[J]. 创伤与急危重病医学, 2020, 8(2): 91-93, 96. DOI: 10.16048/j.issn.2095-5561.2020.02.08.
    [32]
    SHANG J, WANG M, WEN Q, et al. A novel prognostic model to predict outcome of artificial liver support system treatment[J]. Sci Rep, 2021, 11(1): 7510. DOI: 10.1038/s41598-021-87055-8.
    [33]
    SARIN SK, CHOUDHURY A. Management of acute-on-chronic liver failure: An algorithmic approach[J]. Hepatol Int, 2018, 12(5): 402-416. DOI: 10.1007/s12072-018-9887-5.
    [34]
    BAÑARES R, NEVENS F, LARSEN FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial[J]. Hepatology, 2013, 57(3): 1153-1162. DOI: 10.1002/hep.26185.
    [35]
    GERTH HU, POHLEN M, THÖLKING G, et al. Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure-a retrospective analysis[J]. Crit Care Med, 2017, 45(10): 1616-1624. DOI: 10.1097/CCM.0000000000002562.
    [36]
    WAN YM, LI YH, XU ZY, et al. Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir: A prospective study[J]. J Clin Apher, 2017, 32(6): 453-461. DOI: 10.1002/jca.21535.
    [37]
    WU B, DU LY, MA YJ, et al. Effects of different combinations of artificial liver support system on efficacy and inflammatory indexes of patients with hepatitis B virus-related acute-on-chronic liver failure in early and middle stages[J/CD]. Chin J Liver Dis (Electronic Version), 2021, 13(1): 32-38. DOI: 10.3969/j.issn.1674-7380.2021.01.006.

    吴蓓, 杜凌遥, 马元吉, 等. 不同组合人工肝支持系统治疗乙型肝炎病毒相关早、中期慢加急性肝衰竭患者的疗效及对炎症指标的影响[J/CD]. 中国肝脏病杂志(电子版), 2021, 13(1): 32-38. DOI: 10.3969/j.issn.1674-7380.2021.01.006.
    [38]
    LING Q, XU X, WEI Q, et al. Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure[J]. PLoS One, 2012, 7(1): e30322. DOI: 10.1371/journal.pone.0030322.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (569) PDF downloads(41) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return